EXPERIMENTAL DRUG DEVELPOMENT CENTRE

Classification: Research and Development Institution (Neither a manufacturing factory nor a commercial trader)

Company Overview:

The Experimental Drug Development Centre (EDDC) is a national platform for drug discovery and development hosted by the Agency for Science, Technology and Research (A*STAR) in Singapore. It functions as a translational research organization that bridges the gap between early-stage biomedical research and clinical development.

EDDC focuses on identifying and advancing high-potential therapeutic candidates from Singapore’s public sector research labs. It provides expertise in medicinal chemistry, biology, pharmacology, and clinical development to de-risk projects and prepare them for partnerships with the pharmaceutical and biotechnology industry. As an R&D entity, it does not engage in mass manufacturing or the commercial trading of goods, but rather facilitates the innovation pipeline to translate scientific discoveries into potential new medicines.

The Experimental Drug Development Centre (EDDC) in Singapore primarily focuses on the discovery and early-stage development of novel drug candidates and innovative drug discovery technologies. As a national research platform, it does not produce or sell finished pharmaceutical products directly to consumers or healthcare providers.

Instead, EDDC's main outputs, which can be considered its 'products,' include:

Early-stage drug candidates: These are promising compounds or molecules that have demonstrated potential against various disease targets. They are typically developed up to the pre-clinical or early clinical trial stage.

Proprietary drug discovery platforms and technologies: These are innovative tools, assays, or methodologies developed to accelerate and improve the drug discovery process.

These assets are then typically licensed out to pharmaceutical companies or biotech firms for further clinical development, manufacturing, and commercialization. EDDC's research efforts span therapeutic areas such as oncology, infectious diseases, and metabolic diseases, among others.